Position in DHR
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$288,386
+$42,286 QoQ
Shares Held
1,514
+16.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,614
of 2,098 holders
Holding Since
Sep 2021
7 quarters on record
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026KELLEHER FINANCIAL ADVISORS holds $2,291,598 across 9 Diagnostics & Research names. DHR ranks #5 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
1,042 | $548,550 | |
| 2 | LH |
Labcorp Holdings Inc.
|
1,500 | $420,000 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
824 | $413,120 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
1,500 | $289,830 | |
| 5 | DHR |
Danaher Corp /De/
This page
|
1,514 | $288,386 | |
| 6 | DGX |
Quest Diagnostics Inc
|
1,080 | $228,906 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
50 | $63,875 | |
| 8 | NEO |
Neogenomics Inc
|
2,000 | $29,180 |
All Filings in DHR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $288,386 | 1,514 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $246,100 | 1,298 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $182,677 | 798 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $207,974 | 1,049 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $236,652 | 1,198 | Shares | Sole | 2025-08-08 | |
| 2022-06-30 | $241,858 | 954 | Shares | Sole | 2022-08-15 | |
| 2021-09-30 | $370,807 | 1,218 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||